Académique Documents
Professionnel Documents
Culture Documents
DOI 10.1007/s10067-011-1788-0
ORIGINAL ARTICLE
Received: 22 March 2011 / Revised: 19 May 2011 / Accepted: 27 May 2011 / Published online: 14 June 2011
# Clinical Rheumatology 2011
according to the factor analysis, while LAI-knee supported both a single and a two-factor solution (items 1
6b and 710, respectively). At Rasch analysis, the rating
categories of item maximum distance walked did not
comply with the criteria for category functioning in
either LAI-hip or LAI-knee. A test of the residual
correlation showed item dependency in both LAI-hip
and LAI-knee. Misfitting items were present in both the
scales. According to both CTT and Rasch analysis, in our
two samples representing a wide spectrum of both hip
and knee OA severity the LAI-hip and LAI-knee showed
a series of drawbacks, which rendered both questionnaires inadequate in relation to their metric properties
and severely limit their ability to perform, as a composite
measure, in line with the main aims of their developers.
Keywords Lequesne Algofunctional indexes .
Osteoarthritis . Outcome measure . Rasch analysis
A. Giordano
e-mail: andrea.giordano@fsm.it
Introduction
M. Ottonello
e-mail: marcella.ottonello@fsm.it
F. Salaffi (*) : A. Ciapetti (*)
Department of Rheumatology,
Politechnic University of the Marche,
Ancona, Italy
e-mail: fsalaff@tin.it
e-mail: ciapetti.a@libero.it
M. Carotti
Department of Radiology,
Politechnic University of the Marche,
Ancona, Italy
e-mail: marina.carotti@gmail.com
114
included were those who had pain for more than 25 days of
the past 30 days and at least two of the following three
criteria: erythrocyte sedimentation rate <20 mm/h, osteophytes
or obliteration of joint space on local X-ray examination.
The exclusion criteria were as follows: concurrent
systemic inflammatory rheumatic disease, medical comorbidity that would render the patient unable to participate
fully in study procedures (e.g. terminal conditions such as
end-stage renal disease, heart failure or malignancy),
alcohol abuse, psychiatric disorder, or the patients having
undergone arthroplasty of the joint in question.
All OA patients had radiographs of their affected joints.
Radiographs of the knees were anteroposterior (AP)
weight-bearing, semiflexed view, whereas an AP pelvis
radiograph was collected on hip patients. The radiographs
used in this study were generally obtained within 1 year
from the date of the questionnaire assessments.
Measures
The Lequesne Algofunctional Indexes of severity for OA of
the hip (LAI-hip) and knee (LAI-knee) include three sections
(which are not graded separately) and take a few minutes to
complete [15] (Tables 1 and 2). They were developed using
an interview format with a total of ten questions, although
question 6 maximum distance walked could be split into
two, in that the use of one or two walking aids (which increases
the score by one or two points) is arguably an additional item.
Indeed, the self-administered version includes the use of
walking aids as an 11th question (item 6b in Tables 1 and 2)
[17, 18]. For the purposes of this study we chose to use the
self-administered format because in clinical trials it allows for
mailing to patients. Both Lequesne indexes are scored as the
sum of all items, resulting in a total score ranging from 0 to
24. Higher scores denote greater OA severity.
Statistical analysis
115
LAI-hip
Items
Pain or discomfort
1. During nocturnal bed rest
None or insignificant
Only on movement or on certain positions
With no movement
2. Morning stiffness or regressive pain after rising
1 min or less
More than 1 but less than 15 min
15 min or more
3. After standing for 30 min
No
Yes
4. While ambulating
Points
0
1
2
0
1
2
0
1
None
Only after ambulating some distance, or after
initial ambulation, not increasingly
Early after initial ambulation and increasingly with
continued ambulation
5. With prolonged sitting (2 h)
0
1
None
Yes
Maximum distance walked (may walk with pain)
6a. Maximum distance walked
Unlimited
More than 1 km but limited
About 1 km or about 15 min
From 500 to 1,000 m or 815 min
From 300 to 500 m
From 100 to 300 m
Less than 100 m
6b. Use of a walking aid
None
One walking stick or crutch
Two walking sticks or crutches
Activities of daily living
7. Put on socks by bending forward
8. Pick up an object from the floor
0
1
0
1
2
3
4
5
6
0
1
2
0
0.5
1
1.5
2
Pain or discomfort
1. During nocturnal bed rest
None or insignificant
Only on movement or on certain positions
With no movement
2. Morning stiffness or regressive pain after rising
1 min or less
More than 1 but less than 15 min
15 min or more
3. After standing for 30 min
No
Yes
4. While ambulating
Points
0
1
2
0
1
2
0
1
None
Only after ambulating some distance or after initial
ambulation, not increasingly
Early after initial ambulation and increasingly with
continued ambulation
5. When getting up from sitting without the help of arms
0
1
None
Yes
Maximum distance walked (may walk with pain)
6a. Maximum distance walked
Unlimited
More than 1 km but limited
About 1 km or about 15 min
From 500 to 1,000 m or 815 min
From 300 to 500 m
From 100 to 300 m
Less than 100 m
6b. Use of a walking aid
None
One walking stick or crutch
Two walking sticks or crutches
Activities of daily living
7. Able to climb up a standard flight of stairs?
8. Able to climb down a standard flight of stairs?
0
1
0
1
2
3
4
5
6
0
1
2
0
0.5
1
1.5
2
116
Results
Characteristics of patients
The mean age of the sample was 72.1 years (standard
deviation (SD), 10.5) for hip OA and 71.9 years (SD, 9.8)
for knee OA. Of the patients, 71.8% (n=872) were female
(n=371 with hip OA, n=501 with knee OA). Of the 1,214
enrolled subjects, 909 (74.8%) reported one or more
medical comorbidities, mostly cardiovascular (50.7%),
endocrinological (13.2%), gastrointestinal (11.8%) and
respiratory (11.5%) disorders. The LAI-hip median score
(interquartile range (IQR)) was 12 (IQR=6), the LAI-knee
median score (IQR) was 11.5 (IQR=7.5).
117
118
Fig. 2 Person ability and item difficulty map of both LAI-hip (left side)
and LAI-knee (right side). The vertical line represents the measure of
OA severity, with the units of measurement on the scale (logits, the
natural logarithm of the odds of mutually exclusive alternatives, e.g. pass
vs. fail or higher response vs. lower response). The left-hand column
locates the person ability measures along the variable, while the right-
hand column locates the item difficulty measures along the variable.
Each item is indicated by its number (see Table 1). By convention, the
average difficulty of items in the test is set at 0 logits (and indicated with
M), so that items with a positive/negative sign are harder than average,
and those with a negative/positive sign are easier than average.
Accordingly, a candidate with average ability is indicated by an M
Discussion
The purpose of this study was to perform a comprehensive psychometric analysis of LAI-hip and LAI-knee,
using both CTT and Rasch analysis in order to better
understand the strengths and weaknesses of the two
instruments, and provide a rational basis for improving
their metric quality (it was not our intention to propose
revised versions). Hence, we focused on analysing
dimensionality and rating scale diagnostics, and identifying those items most useful for measuring the intended
construct (model fit). The Cronbach alpha (0.820.84)
and item-to-total statistics indicateaccording to CTT
an adequate homogeneity of the items of both scales.
This finding is consistent with previous studies reporting
Cronbachs alpha values ranging from 0.58 [22] to 0.84
for LAI-hip [21] and from 0.75 [39] to 0.82 [17] for LAIknee. A similar reliability was found with the Rasch
analysis (person separation reliability), with results ranging from 0.82 (LAI-knee) to 0.85 (LAI-hip). The internal
consistency of both scales seems adequate only for making
group comparisons [33, 40] and does not allow to
standardize decisions in individuals (e.g. regarding the
need for hip or knee replacement) [21]. In addition, the use
of the raw score seems inappropriate because items have
very different rating points, not properly weighted.
As for unidimensionality, no standard approach exists to
determine whether an outcome measure is sufficiently
unidimensional or when the presence of secondary dimensions threatens the accuracy of unidimensional Rasch
calibrations. The most used approaches are derived from
the factor analysis: EFA is used to study the relevant latent
factors (after some form of estimation of their number) and
the contribution of individual items to those traits in new or
modified models (e.g. following language adaptation) [26].
In the present study, the factor analysis hinted at two factors
in LAI-knee, the first one largely prevailing with a high
inter-factor correlation; these results, along with subsequent
Rasch analysis (PCA of residuals and split-sample correlation), supported an underlying responses structure sufficiently
unidimensional to allow further analysis using Rasch methods.
It seems reasonable that analyses based on different clinical
samples and extraction methods could lead to somewhat
different statistical solutions, also in terms of subscale content
[21]. In any case, we think that an instrument for examining
the severity of hip and knee OA should separately rate
functional difficulty and functional pain [41].
119
120
References
1. Salaffi F, De Angelis R, Grassi W, MArche Pain Prevalence,
INvestigation Group (MAPPING) study (2005) Prevalence of
musculoskeletal conditions in an Italian population sample: results
of a regional community-based study I. The MAPPING study.
Clin Exp Rheumatol 23:819828
2. Salaffi F, De Angelis R, Stancati A, Grassi W, on behalf of
MArche Pain Prevalence INvestigation Group (MAPPING) study
(2005) Health-related quality of life in multiple musculoskeletal
conditions: a cross-sectional population based epidemiological
study II. The MAPPING study. Clin Exp Rheumatol 23:829839
3. Salaffi F, Carotti M, Grassi W (2005) Health-related quality of life
in patients with hip or knee osteoarthritis: comparison of generic
and disease-specific instruments. Clin Rheumatol 24:2937
4. Leardini G, Salaffi F, Caporali R, Canesi B, Rovati L, Montanelli
R et al (2004) Direct and indirect costs of osteoarthritis of the
knee. Clin Exp Rheumatol 22:699706
5. Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P et
al (1997) Recommendations for a core set of outcome measures
for future phase III clinical trials in knee, hip, and hand
osteoarthritis: consensus development at OMERACT III. J
Rheumatol 24:799802
6. World Health Organization, Regional Office for Europe (1985)
Guidelines for the clinical investigation of drugs used in
rheumatic diseases: European drug guidelines. Series 5. European
League Against Rheumatism, Copenhagen
7. Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr
DB et al (2003) Core outcome domains for chronic pain clinical
trials: IMMPACT recommendations. Pain 106:337345
8. Dworkin RH, Turk DC, Peirce-Sandner S, Baron R, Bellamy N,
Burke LB et al (2010) Research design considerations for
confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain 149:177193
9. Altman R, Brandt T, Hochberg M, Moskovitz R (1996) Design
and conduct of clinical trials of patients with osteoarthritis.
Recommendations from a task force of the Osteoarthritis Research
Society. Osteoarthr Cartil 4:217243
10. Lequesne M (1993) ILAR guidelines for testing slow acting drugs
in osteoarthritis (SYSADOAs). Rev Esp Rheumatol 20:220221
11. Bellamy N (1995) Outcome measurement in osteoarthritis clinical
trials. J Rheumatol Suppl 43:4951
12. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW
(1988) Validation study of WOMAC: a health status instrument
for measuring clinically important patient relevant outcomes to
antirheumatic drug therapy in patients with osteoarthritis of the
hip or knee. J Rheumatol 15:18331840
13. Nilsdotter AK, Lohmander LS, Klassbo M, Roos EW (2003) Hip
disability and osteoarthritis outcome score (HOOS) e validity and
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
121
28. Cimmino MA, Salaffi F, Olivieri I, Trotta F, Frizziero L, Sarzi Puttini
P et al (2004) Pain patterns in Italian patients with osteoarthritis:
preliminary results of the MI.D.A. Study (Misurazione del Dolore
nellArtrosi). Reumatismo 56:253261
29. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K et al
(1986) Development of criteria for the classification and reporting
of osteoarthritis: classification of osteoarthritis of the knee.
Arthritis Rheum 29:10391049
30. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D,
Brandt K et al (1991) The American College of Rheumatology
criteria for the classification of osteoarthritis of the hip. Arthritis
Rheum 34:505514
31. Streiner DL, Norman GR (1995) Health measurement scales. A
practical guide to their development and use, 2nd edn. Oxford
University Press, Oxford, pp 163180
32. Lorenzo-Seva U, Ferrando PJ (2006) FACTOR: a computer
program to fit the exploratory factor analysis model. Behav Res
Methods Instrum Comput 38:8891
33. Coste J, Boue S, Ecosse E, Leplge A, Pouchot J (2005)
Methodological issues in determining the dimensionality of
composite health measures using principal component analysis: case
illustration and suggestions for practice. Qual Life Res 14:641654
34. Horn JL (1965) A rationale and test for the number of factors in
factor analysis. Psychometrika 30:179185
35. Velicer WF (1976) Determining the number of components from
the matrix of partial correlations. Psychometrika 41:321327
36. Guadagnoli E, Velicer WF (1988) Relation to sample size to the
stability of component patterns. Psychol Bull 103:265275
37. Linacre JM (2009) A users guide to WINSTEPS-MINISTEP:
Rasch-model computer programs. Program manual 3.68.0. Chicago, IL: WINSTEPS.com. http://www.winsteps.com/a/winsteps.
pdf. Accessed 24 Sept 2009
38. Linacre JM (2002) Optimizing rating scale category effectiveness.
J Appl Meas 3:85106
39. Bae SC, Lee HS, Yun HR, Kim TH, Yoo DH, Kim SY (2001) Crosscultural adaptation and validation of Korean Western Ontario and
McMaster Universities (WOMAC) and Lequesne osteoarthritis
indices for clinical research. Osteoarthr Cartil 9:746750
40. Bland JM, Altman DG (1997) Cronbachs alpha. BMJ 314(7080):572
41. Jette AM, McDonough CM, Ni P, Haley SM, Hambleton RK,
Olarsch S et al (2009) A functional difficulty and functional pain
instrument for hip and knee osteoarthritis. Arthritis Res Ther 11:R107
42. Merbitz C, Morris J, Grip JC (1989) Ordinal scales and
foundations of misinference. Arch Phys Med Rehabil 70:308312
43. Hopman-Rock M, Odding E, Hofman A, Kraaimaat FW, Bijlsma
JWJ (1997) Differences in health status of older adults with pain
in the hip or knee only and with additional mobility restricting
conditions. J Rheumatol 24:24162423
44. Lequesne MG (1997) The algofunctional indices for hip and knee
osteoarthritis. J Rheumatol 24:779781
45. Perruccio AV, Stefan Lohmander L, Canizares M, Tennant A,
Hawker GA, Conaghan PG et al (2008) The development of a
short measure of physical function for knee OA KOOS-Physical
Function Shortform (KOOS-PS)an OARSI/OMERACT initiative. Osteoarthr Cartil 16:542550
46. Davis AM, Perruccio AV, Canizares M, Tennant A, Hawker GA,
Conaghan PG et al (2008) The development of a short measure of
physical function for hip OA HOOS-Physical Function Shortform
(HOOS-PS): an OARSI/OMERACT initiative. Osteoarthr Cartil
16:551559